Molecular docking and quantitative structureactivity relationships for a series of Trypanosoma cruzi dihydroorotate dehydrogenase inhibitors (2025)
- Authors:
- USP affiliated authors: ANDRICOPULO, ADRIANO DEFINI - IFSC ; FERREIRA, LEONARDO LUIZ GOMES - IFSC
- Unidade: IFSC
- DOI: 10.1590/s2175-97902025e24064
- Subjects: TRYPANOSOMA CRUZI; MODELAGEM MOLECULAR; DOENÇA DE CHAGAS; PLANEJAMENTO DE FÁRMACOS; QUÍMICA MÉDICA
- Keywords: Trypanosoma cruzi; Medicinal chemistry; QSAR; Dihydroorotate dehydrogenase; Inhibitors; Chagas disease
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 61, p. e24064-1-e24064-28, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
JESUS, Gabriela Cifelli de et al. Molecular docking and quantitative structureactivity relationships for a series of Trypanosoma cruzi dihydroorotate dehydrogenase inhibitors. Brazilian Journal of Pharmaceutical Sciences, v. 61, p. e24064-1-e24064-28, 2025Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902025e24064. Acesso em: 19 fev. 2026. -
APA
Jesus, G. C. de, Ribeiro, T. S., Andricopulo, A. D., & Ferreira, L. L. G. (2025). Molecular docking and quantitative structureactivity relationships for a series of Trypanosoma cruzi dihydroorotate dehydrogenase inhibitors. Brazilian Journal of Pharmaceutical Sciences, 61, e24064-1-e24064-28. doi:10.1590/s2175-97902025e24064 -
NLM
Jesus GC de, Ribeiro TS, Andricopulo AD, Ferreira LLG. Molecular docking and quantitative structureactivity relationships for a series of Trypanosoma cruzi dihydroorotate dehydrogenase inhibitors [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2025 ; 61 e24064-1-e24064-28.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1590/s2175-97902025e24064 -
Vancouver
Jesus GC de, Ribeiro TS, Andricopulo AD, Ferreira LLG. Molecular docking and quantitative structureactivity relationships for a series of Trypanosoma cruzi dihydroorotate dehydrogenase inhibitors [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2025 ; 61 e24064-1-e24064-28.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1590/s2175-97902025e24064 - Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation
- 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors
- COVID-19: small-molecule clinical trials landscape [Editorial]
- Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies
- Cancer estimates in Brazil reveal progress for the most lethal malignancies [Editorial]
- In vitro leishmanicidal activity of novel N-arylspermidine derivatives
- Chemoinformatics approaches to structure- and ligand-based drug design
- Empowering neglected tropical disease drug discovery with translational medicinal chemistry. [Editorial]
- World chagas disease day and the new road map for neglected tropical diseases. [Editorial]
- Evaluation of pyrazolines as anti-alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies
Informações sobre o DOI: 10.1590/s2175-97902025e24064 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
PROD036849_3234316.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
